EC
Insider
E Thomas Corcoran
DirectorE Thomas Corcoran (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Phibro Animal Health Corporation (PAHC). Across 1 priced purchase filing, the average 21-session return was +0.6% from execution and +8.1% from disclosure (delay-adjusted; derived). The largest single filing was $318K of PAHC (10,000 sh × $31.77, as filed), executed May 29.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+0.6%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+8.1%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$318K
shares × price, as filed
Last traded
May 29
Filed Jun 2
Median ADV $13.2M across their filed names
Open performance→Volume by month
Buys $428K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
PAHCRecent filings
PAHCPURCHASE
Phibro Animal Health Corporation
View filing →
$318K10,000 sh × $31.77
Exec May 29
Filed Jun 2 · 6:56 PM ET PAHCPURCHASE Phibro Animal Health Corporation View filing → $110K
5,000 sh × $22.10
Exec Feb 24 2025
Filed Feb 26 2025 · 5:30 PM ET